The most common irAEs that we identified for patients experiencing multisystem irAEs were dermatitis, colitis, hepatotoxicity, and thyroiditis, similar to the findings for multisystem irAEs with single-agent PD-(L)1 inhibitors [9]. Here, CD274 is linked to colitis.